Noonberg Sarah B.
- SEC CIK
- 0001706301
No open-market purchases or sales filed in the past year.
Current role at each company
- NGNE Neurogene Inc.Directoras of Feb 24, 2026
- MGX Metagenomi Therapeutics, Inc.Chief Medical Officeras of Jun 9, 2025
- MRNS Marinus Pharmaceuticals, Inc.Directoras of Jun 20, 2024
- PTGX Protagonist Therapeutics, IncDirectoras of Jan 18, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Noonberg Sarah B. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
MGX Metagenomi Therapeutics, Inc.
Chief Medical Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 9, 2025 (view filing) | Jun 6 | 3 days | Noonberg Sarah B.Chief Medical Officer | SSale | −5.24K | $1.75 | −$9.17K | −4.6%109.1K after |